Fundraising Fox

Breatheasy MIIST

Alameda, US · Founded 2019 · Delaware corporation · 2 known investors

miisttherapeutics.com

Miist develops inhaled microparticle therapeutics that deliver medicine to the bloodstream in 30 seconds, targeting conditions like migraine, pain, and anxiety where rapid onset is critical. The company is advancing a portfolio of systemic therapies starting with MST-02, a migraine treatment designed to work significantly faster than existing oral medications.

BiotechHealthtechMedical Devicesin /miisttherapeutics

Founders & leadership

EE
Eric EzerinsinCofounder, Head of Technology
DS
Dalton SignorinCofounder, CEO
RK
Randy KrebsExecutive Officer
EA
Evan AlfanoDirector
JS
Jeffrey SchusterChief Technology Officer

Investors · 2

Reported raises · per SEC filings

Form D private placements
$6.3MraisedSep 2024 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Randy KrebsExecutive Officer
  • Dalton SignorExecutive Officer, Director, Promoter
Offering amount
$8.4M
Amount sold
$6.3M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$75KraisedOct 2022 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dalton SignorExecutive Officer, Director
  • Randy KrebsExecutive Officer, Director
  • Evan AlfanoDirector
  • Eric EzerinsExecutive Officer
  • Jeffrey SchusterExecutive Officer
Offering amount
$75K
Amount sold
$75K
First sale
Sep 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.